PRESENCE SAINTS MARY & ELIZABETH MED — History
CCN 140180 | 3-year financial timeline | COVID resilience: 76/100
🛡️ Public data only — no PHI permitted on this instance.
$365M
Latest Revenue (FY2022)
+11.7%
Revenue CAGR (3yr)
3.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $292M | $326M | $365M | +11.7% | +11.7% |
| Operating Expenses | $310M | $316M | $351M | +10.9% | +6.4% |
| Operating Margin | -6.2% | 3.0% | 3.7% | +22.9% | +0.0% |
| Net Income | $-18M | $10M | $13M | +37.3% | +0.0% |
| Licensed Beds | 294 | 302 | 266 | -11.9% | -4.9% |
| Total Patient Days | 75,316 | 72,614 | 71,890 | -1.0% | -2.3% |
| Medicare Day % | 22% | 19% | 19% | -1.4% | -7.1% |
| Medicaid Day % | 11% | 9% | 8% | -11.5% | -15.3% |
COVID Impact & Recovery
Resilience Score: 76/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +24.8% ($292M → $365M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.7%
This Hospital
+7.6%
State Avg
Latest Margin
3.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $401M | 8.6% |
| FY2024 (proj) | $437M | 13.6% |
| FY2025 (proj) | $473M | 18.5% |